Status:
TERMINATED
Microparticles in Pediatric Inflammatory Disease
Lead Sponsor:
Indiana University
Conditions:
Crohn's Disease
Ulcerative Colitis
Eligibility:
All Genders
8-17 years
Brief Summary
The purpose of this study is to provide data correlating levels of microparticles that circulate in the blood and disease activity in children with inflammatory bowel disease (IBD). The hypothesis is ...
Detailed Description
Once the response of microparticles to inflammation is defined in this patient population, the microparticles can be used as biomarkers of disease activity and could potentially use microparticles as ...
Eligibility Criteria
Inclusion
- Children with IBD based on endoscopic, histologic, radiologic, or laboratory data
- Ages between 8 and 17 years old
Exclusion
- Anyone with a concurrent illness since infection can affect microparticle levels
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00979485
Start Date
August 1 2009
End Date
May 1 2011
Last Update
June 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana Unversity, Riley Hospital for Children
Indianapolis, Indiana, United States, 46202